Efficacy of BCG for non-muscle invasive bladder cancer following nephr... Hoping to discover improved treatment strategies to decrease bladder cancer recurrences after nephroureterectomy sciencedirect.com/science/articl…

New UF cancer vaccine triggers fierce immune response in first human trials mainstreetdailynews.com/health/uf-heal… via Mainstreet Daily News Gainesville UF Health Cancer Center

Looking forward to ⁦Joshua Meeks⁩ joining us for ⁦UF Health Cancer Center⁩ grand rounds this week cancercenter-a2.sites.medinfo.ufl.edu/wordpress/file…

The stars came out for the NRG Oncology Winter 2024 meeting. Scott Delacroix M.D. Brian F. Chapin . Great to have them join the GU sessions

Congratulations to Dr Jon Chatzkel for leading UF Health Cancer Center in clinical trial enrollments in 2023 Jonathan Licht, MD

Study: UF leads world for published gene therapy research mainstreetdailynews.com/education/uf-l… via Mainstreet Daily News Gainesville

Thank you Ocala Royal Dames for Cancer Research for the opportunity to discuss improving the diagnosis for of Prostate Cancer and all of your tremendous research support UF Health Cancer Center UF Urology

UF Health teams up with Olympic medical network  mainstreetdailynews.com/news/local/uf-… via Mainstreet Daily News Gainesville

UF Health tests new blood management program mainstreetdailynews.com/health/uf-heal… via Mainstreet Daily News Gainesville

What do you need to know about the PREDICT-RT study for high-risk #prostatecancer - Paul Nguyen discusses the details of the trials. FULL VIDEO: youtube.com/watch?v=2wSAuI… Dana-Farber Brigham and Women's Hospital #pcsm

Looking forward to NRG GU-013. (High Five) Will help answer a critical question in patients with high risk prostate cancer. NRG Oncology #NRG2023

NRG GU-009 off to a great start in evaluating treatment intensification and deintensification for intermediate risk prostate cancer. NRG Oncology UF Health Cancer Center

Thank you to all for accruing to NRG 009. Very impressive enrollment rate. NRG Oncology UF Health Cancer Center

Hiro Miyagi evaluates response rates to neoadjuvant chemotherapy in patients with primary and secondary MIBC. On her way to Moffitt Cancer Center for an SUO fellowship UF Urology UF Health Cancer Center Southeastern Section

Michael Massari reports decreased response rates to BCG for NMIBC after nephroureterectomy. Advocates for trial to improve outcomes. UF Urology UF Health Cancer Center Southeastern Section

Elizabeth Kwenda presents use of a urinary exsome biomarker to predict csPCa following negative MRI UF Urology UF Health Cancer Center Wayne Brisbane Southeastern Section

Excited to open and offer NRG GU- 010 to our patients UF Health Cancer Center UF Urology NRG Oncology

Please join us for the next FUS Journal Club Webinars us02web.zoom.us/meeting/regist… Florida Urological Society (FUS)

Thank you to our outstanding Visiting Professor Dr. Seth Lerner UF Urology

Awesome to see Candace Granberg, MD in the spotlight. A truly amazing leader.